Global Cell Harvesting Market Research Covers, Future Trends and Deep Analysis 2024-2032

Cell Harvesting Market Size And Forecast

Cell Harvesting Market size was valued at USD 21.11 Billion in 2024 and is projected to reach USD 30.82 Billion by 2031, growing at a CAGR of 5.34% from 2024 to 2031.

• Cell harvesting is the process of removing cells from their culture environment, which is necessary in many biotechnological and medicinal applications. This operation entails separating the cells from the growing medium and removing contaminants such as cell debris and soluble chemicals to provide high-quality yields for later processing.
• Cell harvesting techniques include centrifugation, microfiltration, and depth filtration, which are chosen based on the cell culture’s individual features and intended purpose.
• Furthermore, cell harvesting has a wide range of applications, including vaccine development, therapeutic protein manufacturing, and cell-based therapeutics.

Global Cell Harvesting Market Dynamics

The key market dynamics that are shaping the cell harvesting market include:

Key Market Drivers

• Increasing Prevalence of Chronic Diseases: The increasing prevalence of chronic diseases, particularly cancer, is a significant driver of the cell harvesting market. According to the World Health Organization (WHO), cancer is the world’s second biggest cause of death, with an expected 9.6 million deaths in 2018. The demand for cell-based treatments in cancer therapy is driving the expansion of the cell harvesting market, as these therapies necessitate efficient cell separation and harvesting methodologies.
• Rising Investments in Stem Cell Research: Large investments in stem cell research and regenerative medicine are driving the cell harvesting market ahead. According to the National Institutes of Health (NIH), funding for stem cell research increased from $1.3 billion in 2017 to USD 1.8 Billion by 2021. This increase in financing is pushing innovation in cell harvesting technologies and increasing their uses in various therapeutic areas.
• Advancements in Automated Cell Harvesting Systems: The introduction of automated cell harvesting systems is propelling market growth. The International Federation of Robotics (IFR) reports that global sales of medical robots, including those used in cell harvesting, climbed by 28% to 14,823 units in 2020. The deployment of these automated technologies improves the efficiency and repeatability of cell harvesting operations, ultimately boosting market expansion.

Key Challenges:

• High Costs of Advanced Technologies: Many research institutes and smaller biotech enterprises cannot afford to implement sophisticated cell harvesting technologies, such as automated systems and specialized equipment. This price barrier limits access to cutting-edge procedures, forcing harvesters to rely on traditional, less efficient ways. As a result, the high prices associated with new technology impede market expansion and innovation.
• Competition from Alternative Techniques: The introduction of single-use bioprocessing containers and various alternative cell processing methods has posed a serious challenge to the traditional cell harvesting market. These options provide more cost-effective and efficient cell collecting and processing solutions, prompting a shift in end-user preferences. As a result, traditional cell harvesting methods have experienced decreased demand, affecting overall market dynamics.

Key Trends:

• Growth in Stem Cell Research: The cell harvesting market is expanding rapidly due to rising funding in stem cell research. Funding from the public and private sectors is increasing, with noteworthy contributions such as the NIH’s USD 2,279 million allocation for 2022. This increased financial backing is likely to help accelerate the development of stem cell-based medicines and products, generating demand for effective cell harvesting procedures in research and clinical settings.
• Technological Advancements: The market is shifting towards automation and improved technologies in cell harvesting operations. Automated systems increase efficiency, lower contamination hazards, and improve yield quality, making them more popular among biopharmaceutical organizations. As research institutions and biotech corporations implement these advancements, the demand for automated cell harvesting systems will expand, facilitating the manufacturing of high-quality biologics and regenerative medicines.
• Rising Incidence of Chronic Diseases: The increasing frequency of chronic diseases, such as cancer and diabetes, is having a substantial impact on the cell harvesting market. As the demand for novel therapeutic alternatives increases, there is a greater emphasis on using stem cells and other cellular therapies for disease management. This trend is driving biopharmaceutical research and development, increasing the need for effective cell harvesting systems to aid in the manufacturing of therapeutics.

Global Cell Harvesting Market Regional Analysis

Here is a more detailed regional analysis of the cell harvesting market:

North America:

• According to Market Research, North America is estimated to dominate the cell harvesting market over the forecast period. North America’s advanced healthcare infrastructure, as well as significant investment in R&D, drive the cell harvesting market. According to the National Center for Science and Engineering Statistics, the United States spent USD 612 Billion on R&D in 2019, with a significant chunk going toward life sciences. This high level of investment promotes innovation in cell harvesting technology while also supporting regional market expansion.
• The rising prevalence of chronic diseases in North America, particularly cancer, is a significant driver of the cell harvesting market. The American Cancer Society estimates that there were 1.9 million new cancer cases identified in the United States in 2021. This high disease load needs enhanced treatment alternatives, including cell-based medicines that rely on effective cell harvesting techniques, propelling the market.
• Furthermore, North America leads in the use of regenerative medicine, which is highly reliant on cell harvesting technologies. According to the Alliance for Regenerative Medicine, North America had 1,085 regenerative medicine clinical trials underway in 2020, accounting for 59% of the global total. The region’s cell harvesting market is being driven by a strong focus on regenerative medicine applications.

Asia Pacific:

• The Asia Pacific region is estimated to exhibit the highest growth potential in the market during the forecast period. The Asia Pacific region’s biotechnology and pharmaceutical sectors are rapidly expanding, increasing demand for cell harvesting technologies. According to an Asia Pacific Economic Cooperation (APEC) report, the APEC region’s biotechnology market was worth USD 216.7 Billion in 2018 and is expected to reach USD 323.1 Billion by 2025, rising at a 5.9% CAGR. This expansion is driving up investment in cell-based research and therapeutics, hence strengthening the cell harvesting market.
• The increasing prevalence of cancer and other chronic diseases in the Asia-Pacific region is a primary driver of the cell harvesting market. According to the World Health Organization (WHO), the Asia-Pacific region accounts for over half of the worldwide cancer burden, with 8.8 million new cases and 5.5 million cancer deaths in 2018. This high disease burden is propelling the demand for advanced cell-based therapies and, consequently, cell harvesting technologies.
• Furthermore, government support and financing for stem cell research in various Asia Pacific countries are propelling the cell harvesting market. For example, the Japanese government set up 9.1 billion yen (about USD 80 Million) for regenerative medicine research in the 2020 fiscal year. Similarly, the Indian Council of Medical Research (ICMR) reported a 3.5-fold increase in stem cell research funding between 2016 and 2020. These projects promote innovation in cell harvesting techniques and broaden their applications.

Europe:

• Europe region is estimated to exhibit substantial growth during the forecast period. The growing aging population in Europe is a major driver of the region’s cell harvesting market. According to Eurostat, the proportion of individuals aged 65 and up in the EU-27 is expected to rise from 20.3% in 2019 to 29.4% in 2050. This demographic transition has been linked to an increase in the frequency of age-related diseases such as cancer and cardiovascular ailments, both of which require cell-based treatment. The European Cancer Information System estimated 2.7 million new cancer cases in Europe in 2020, underlining the growing need for better cell harvesting technology.
• Furthermore, Europe’s strong research infrastructure and significant funding for regenerative medicine and cell therapy research are propelling the cell harvesting market. The European Commission’s Horizon Europe initiative has set aside €95.5 billion for research and innovation between 2021 and 2027, with a large chunk dedicated to health research. Also, since 2008, the European Union’s Innovative Medicines Initiative (IMI) has spent more than €5 billion in public-private partnerships for health research, accelerating breakthroughs in cell harvesting technologies and applications.

Global Cell Harvesting Market: Segmentation Analysis

The market is segmented based on Type, Application, End-User, and Geography.

Cell Harvesting Market, By Type

• Manual Cell Harvesters
• Automated Cell Harvesters

Based on Type, the market is segmented into Manual Cell Harvesters and Automated Cell Harvesters. The automated cell harvester segment is estimated to dominate the cell harvesting market due to its efficiency, precision, and capacity to reduce human error when compared to manual approaches. Automated harvesting methods improve throughput and consistency in quality, which is critical for biopharmaceutical applications. As the need for high-quality cell products rises, automated solutions are projected to gain traction, consolidating their market leadership.

Cell Harvesting Market, By Application

• Biopharmaceutical
• Stem Cell Research
• Others

Based on Application, the market is divided into Biopharmaceutical, Stem Cell Research, and Others. The biopharmaceutical segment is estimated to dominate the market over the forecast period due to the growing demand for biologics such as monoclonal antibodies and recombinant proteins, which require effective cell harvesting procedures to manufacture. The biopharmaceutical industry’s rapid growth, spurred by increased R&D investments and advancements in bioprocessing technology, increases the demand for effective cell harvesting solutions, consolidating its market leadership.

Cell Harvesting Market, By End-User

• Biotechnology & Biopharmaceutical Companies
• Research Institutes
• Others

Based on End-User, the market is divided into Biotechnology & Biopharmaceutical Companies, Research Institutes, and Others. The biotechnology & biopharmaceutical companies segment is estimated to dominate the market over the forecast period. This dominance is primarily driven by the expanding prevalence of chronic diseases, as well as increased spending in biopharmaceutical research and development. These companies require efficient cell harvesting methods to facilitate the production of medicines and vaccines, which will significantly contribute to the market’s overall growth.

Cell Harvesting Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, the market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America region is estimated to dominate the market during the forecasted period due to factors such as increase in investment in regenerative therapies, a burgeoning biotechnology and biopharmaceutical industry, and the presence of major market participants in the region. The increased prevalence of chronic diseases, as well as ongoing research into stem cell therapies, are driving demand for effective cell harvesting technologies in North America.

Key Players

The “Cell Harvesting Market” study report will provide valuable insight emphasizing the global market. The major players in the market are PerkinElmer, Brandel, TOMTEC, Cox Scientific, Connectorate, Scinomix, ADSTEC, and Terumo BCT.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Cell Harvesting Market Recent Developments

• In October 2022, Thermo Fisher Scientific introduced the DynaSpin Single-Use Centrifuge system, an efficient option for large-scale cell culture harvesting. The technology streamlines the harvest process by minimizing the need for multiple-depth filtration cartridges.

Report Scope

Research Methodology of Market Research:

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report:

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.